Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.

GREY:IMVIF - Post Discussion

IMV Inc > Capitulation
View:
Post by europe10 on Mar 17, 2021 4:06pm

Capitulation

Today,
Was a day of capitulation
Still some capitulation to do for those that invested for COVID-19 vaccine
But "HOUSTON WE GOT A PROBLEM"
When investing there are 3 important parameters
1. Management
2. Management
3. Management
Do we have those 3?
My impresson is that managment care only about institutional investors
That, normally ends with endless dilution
Today, I was close to capitulation myself
Ovarian appears to have failed - or at best is mediocre? Or do I read that wrong?
DLBCL still there -- but....
Bladder pops up -- but nothing for now

As always, I look at the technicals. And risking repeating myself, "the whole worlds knowledge is shown in the stock price". 
And that indicator is not lloking good. As QM wrote, below 3 USD and we are on trouble!

I give IMV a few more weeks. Hoping for a decent deal around DLBCL.
Comment by LR6852 on Mar 17, 2021 5:06pm
Monotherapy for ovarian still viable just not with keytruda.
Comment by qwerty22 on Mar 17, 2021 5:25pm
That's certainly the point Fred was trying to make but again solid numbers would tell that story better than long winded statements.